The funding round was led by Highland Europe alongside participation from Columbia Lake Partners, Finch Capital, Latitude, and Oxx.
"As we continue on our mission to build the best rental experience in the world, bringing Highland Europe and Columbia Lake Partners on board as investors is fantastic news for Goodlord and the rental sector. About one in five people in the UK now live in the private rented sector, supported by millions more private landlords and lettings professionals, making our mission just as important today as it was when Goodlord began."
Scania Growth Capital led the Series A round to support strategic expansion into the US and Europe.
"I formulated the idea for Parcelly because I was dissatisfied with the last-mile delivery experience when placing an order online and it became my mission to change that. What started as a B2C centric consumer app back in 2014 has evolved into the highly scalable B2B technology platform Parcelly is today. We make effective use of available space to offer the broad range of services online retailers and carriers need to meet consumer expectations, efficiency and sustainability goals."
Mercia has backed the employee benefits platform with a £750k injection from its EIS funds.
"There is increasing demand from employee benefits consultancies for a simple, easy-to-use and affordable technology platform that allows them to deliver employee benefit services to their clients more efficiently."
The London-based marketplace secured backing from btov Partners to scale its digital renovation platform across the UK.
"We have been focused on building a platform for home renovation that not only serves an imminent need but will deliver even more value as we scale. Very few industries are as behind as the construction industry, and we are poised to become a game changer that can make home renovation much easier, less risky, and more cost-effective for contractors, architects and homeowners alike."
The Series A round was led by MMC Ventures with participation from Episode 1, Seedcamp, and angel investors.
"Since meeting Patrick and the Sano team, we have been consistently impressed with their unwavering purpose-led strategy to promote access to, and the success of, personalised medicine. To deliver on the promise of this new approach to treatment, there is an urgent need to solve the largest problems in clinical trials: patient recruitment and engagement. This is where Sano’s innovative software platform, which allows them to interact directly with patients, biotech and broader healthcare communities, can be transformational for the future of personalised medicine."
